Clinical Trials on Hypokinesia in Colombia

Total 9 results

University of British Columbia

Completed

Stress Hormones, Mood and Women's Sexual Desire (MODEST) (MODEST)

Hypoactive Sexual Desire Disorder (HSDD)

Canada
BioSante Pharmaceuticals

Completed

Safety and Efficacy of LibiGel® for the Treatment of Hypoactive Sexual Desire Disorder in Surgically Menopausal Women (BLOOM)

Hypoactive Sexual Desire Disorder

United States, Canada
Palatin Technologies, Inc
AMAG Pharmaceuticals, Inc.

Completed

2. Study to Evaluate the Efficacy/Safety of Bremelanotide in Premenopausal Women With Hypoactive Sexual Desire Disorder (HSDD)

Hypoactive Sexual Desire Disorder

United States, Canada
Warner Chilcott

Completed

Endometrial Safety Study of Transdermal Testosterone (300 Mcg/Day) in Naturally Postmenopausal Women

Hypoactive Sexual Desire Disorder

United States
BioSante Pharmaceuticals

Completed

Safety and Efficacy of LibiGel® for Treatment of Hypoactive Sexual Desire Disorder in Surgically Menopausal Women (BLOOM)

Hypoactive Sexual Desire Disorder

United States, Canada
EndoCeutics Inc.

Completed

Prasterone (DHEA) for the Treatment of Hypoactive Sexual Desire Disorder (HSDD)

Hypoactive Sexual Desire Disorder

United States, Canada
BioSante Pharmaceuticals

Completed

Extension Study to Assess Persistence of Benefit of LibiGel for the Treatment of Hypoactive Sexual Desire Disorder (HSDD)

Hypoactive Sexual Desire Disorder

United States, Canada
BioSante Pharmaceuticals

Completed

Safety and Efficacy of LibiGel® for Treatment of Hypoactive Sexual Desire Disorder in Postmenopausal Women (BLOOM)

Hypoactive Sexual Desire Disorder

United States, Canada
Palatin Technologies, Inc

Completed

Bremelanotide in Premenopausal Women With Female Sexual Arousal Disorder and/or Hypoactive Sexual Desire Disorder

Hypoactive Sexual Desire Disorder | Female Sexual Arousal Disorder

United States, Canada

3

Subscribe